
    
      The patient population will consist of adult men and women who have a confirmed diagnosis of
      Multiple Myeloma and who meet eligibility criteria. They will be recruited from among the
      patients consulting in an investigating centre's haematology service for newly diagnosed,
      symptomatic, untreated multiple myeloma.

      in each treatment arm there will be :

        1. Induction therapy : 4 cycles of VTD (21 days)or VCD

        2. Systematic stem cell harvest after cycle 3
    
  